0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

RHEUMATIC AND FEBRILE SYNDROME DURING PROLONGED HYDRALAZINE TREATMENT

Harriet P. Dustan, M.D.; Robert D. Taylor, M.D.; A. C. Corcoran, M.D.; Irvine H. Page, M.D.
JAMA. 1954;154(1):23-29. doi:10.1001/jama.1954.02940350025006.
Text Size: A A A
Published online

Recent experience has extended and confirmed our impressions of the effects of treatment of hypertension with hydralazine hydrochloride (1-hydrazinophthalazine, Apresoline1) as the sole antipressor agent.2 A favorable result is commonly observed; the untoward toxic side-effects, formerly described, appear and usually disappear as the drug is used. In the doses used, tolerance, which others3 using smaller doses have observed, is rare. Some patients have become slightly anemic, partly, it would seem, as a result of anorexia, but severe anemia4 is exceptional.

Another striking complication of treatment has appeared in some of our patients; this seems to be related to the use of large doses of hydralazine over long periods of time. The syndrome in its less severe form resembles rheumatoid arthritis; in its severer febrile aspect, it simulates acute systemic lupus erythematosus. It is described in this report because of the natural interest attached to a complication

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();